房颤最佳治疗与卒中预防的新途径
本综述聚焦房颤与心脑交互,讨论直接口服抗凝药启动时机、与维生素K拮抗剂比较、桥接危害、剂量、筛查、左心耳封堵、早期节律控制、生活方式干预及房颤与痴呆风险等议题,强调多学科协作应对房颤复杂挑战。
要点
- 房颤患者即使无卒中也可增加痴呆风险。
- 直接口服抗凝药早期二级预防需关注启动时机与剂量。
- 高风险人群筛查房颤及可穿戴设备有潜在作用。
核心结论
- 房颤管理需多学科协作以应对卒中预防、痴呆风险等复杂挑战。
研究设计与样本
- 综述,讨论房颤与心脑交互的最新进展。
主要发现
- 55岁时无房颤者一生中约1/3会发展为房颤。
- 房颤不仅增加缺血性卒中风险,在无卒中患者中也增加痴呆风险。
临床怎么用
- 临床应关注直接口服抗凝药的启动时机、剂量及避免肝素桥接。
- 对高风险人群可考虑房颤筛查,包括可穿戴设备。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
One in 3 individuals free of atrial fibrillation (AF) at index age 55 years is estimated to develop AF later in life. AF increases not only the risk of ischemic stroke but also of dementia, even in stroke-free patients. In this review, we address recent advances in the heart-brain interaction with focus on AF. Issues discussed are (1) the timing of direct oral anticoagulants start following an ischemic stroke; (2) the comparison of direct oral anticoagulants versus vitamin K antagonists in early secondary stroke prevention; (3) harms of bridging with heparin before direct oral anticoagulants; (4) importance of appropriate direct oral anticoagulants dosing; (5) screening for AF in high-risk populations, including the role of wearables; (6) left atrial appendage occlusion as an alternative to oral anticoagulation; (7) the role of early rhythm-control therapy; (8) effect of lifestyle interventions on AF; (9) AF as a risk factor for dementia. An interdisciplinary approach seems appropriate to address the complex challenges posed by AF.
引用
- De Marchis GM, Sposato LA, Kühne M, et al. New Avenues for Optimal Treatment of Atrial Fibrillation and Stroke Prevention. Stroke. 2021. PMID: 33626906. doi:10.1161/STROKEAHA.120.032060
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。